Maria L. Ascierto, Ph.D. Saint John's Cancer Institute

Por um escritor misterioso

Last updated 21 outubro 2024

Maria L. Ascierto, Ph.D. Saint John's Cancer Institute

Saint John's Cancer Institute's Director of Translational Immunology, Maria L. Ascierto, Ph.D. Contact Dr. Ascierto via email or phone number.

(PDF) Immune evasion in cancer: Mechanistic basis and therapeutic strategies

Cabrini Research Annual Report 2020-21 by Cabrini Health - Issuu

Previous Issues - JADPRO

View Schedule - SITC 2020

Translational Cancer Immunology

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - ScienceDirect

33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) : Washington, D.C., USA. 7-11 November 2018. - Abstract - Europe PMC